Severe psoriasis--oral therapy with a new retinoid.
作者： T. Fredriksson , U. Pettersson
DOI: 10.1159/000250839
关键词:
摘要: Ro 10–9359 is a retinoic acid derivative, selected for study because of better tolerance than acid, shown in animal experiments. Doses 25 mg b.i.d., t.i.d. and 50 b.i.d. were ad
karger.com
sci-hub.se 参考文章(7)
U. Runne, C. E. Orfanos, H. Gartmann, Perorale Applikation zweier Derivate der Vitamin A-Säure zur internen Psoriasis-Therapie Archiv f�r Dermatologische Forschung. ,vol. 247, pp. 171- 180 ,(1973) , 10.1007/BF00595928
W. Bollag, Antitumor effect of a new retinoic acid analog Cellular and Molecular Life Sciences. ,vol. 30, pp. 1198- 1200 ,(1974) , 10.1007/BF01923688
C.E. Orfanos, U. Runne, Systemic use of a new retinoid with and without local dithranol treatment in generalized psoriasis. British Journal of Dermatology. ,vol. 95, pp. 101- 103 ,(1976) , 10.1111/J.1365-2133.1976.TB15541.X
Werner Bollag, Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice European Journal of Cancer. ,vol. 10, pp. 731- 737 ,(1974) , 10.1016/0014-2964(74)90112-1
Wilfrid Joseph Dixon, Frank Jones Massey, Introduction to Statistical Analysis ,(1969)
G Stüttgen, Oral vitamin A acid therapy. Acta Dermato-venereologica. ,vol. 74, pp. 174- 179 ,(1975)
A. Schumacher, G. Stüttgen, [Vitamin A acid in hyperkeratoses, epithelial tumors and acne] Deutsche Medizinische Wochenschrift. ,vol. 96, pp. 1547- 1551 ,(1971) , 10.1055/S-0028-1110177